Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Rhinoklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   3.8% 5.0% 1.8% 3.3% 3.0% 9.8% 19.6% 19.2%   Credit score (0-100)   53 45 71 53 57 24 6 7   Credit rating   BBB BBB A BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,808 7,097 9,345 9,564 10,501 8,712 0.0 0.0   EBITDA   868 786 1,741 847 1,613 262 0.0 0.0   EBIT   480 377 1,313 330 1,119 73.2 0.0 0.0   Pre-tax profit (PTP)   414.7 298.5 1,252.6 291.4 1,087.4 28.1 0.0 0.0   Net earnings   464.5 215.2 951.0 214.3 821.7 10.7 0.0 0.0   Pre-tax profit without non-rec. items   415 298 1,253 291 1,087 28.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,561 1,292 864 834 503 489 0.0 0.0   Shareholders equity total   1.7 217 1,002 316 522 61.5 11.5 11.5   Interest-bearing liabilities   1,149 1,096 259 837 209 836 0.0 0.0   Balance sheet total (assets)   2,566 2,854 3,477 2,187 2,122 2,381 11.5 11.5   Net Debt   1,133 1,069 -1,145 604 -287 668 -11.5 -11.5     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,808 7,097 9,345 9,564 10,501 8,712 0.0 0.0   Gross profit growth   4,114.2% 22.2% 31.7% 2.3% 9.8% -17.0% -100.0% 0.0%   Employees   3 4 5 5 5 5 0 0   Employee growth %   0.0% 33.3% 25.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,566 2,854 3,477 2,187 2,122 2,381 11 11   Balance sheet change%   67.3% 11.2% 21.8% -37.1% -3.0% 12.2% -99.5% 0.0%   Added value   868.0 786.4 1,740.6 847.0 1,635.9 262.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   105 -678 -856 -546 -824 -203 -489 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.3% 5.3% 14.0% 3.5% 10.7% 0.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.2% 14.0% 41.5% 11.7% 52.0% 3.3% 0.0% 0.0%   ROI %   26.8% 20.1% 73.4% 23.5% 119.0% 9.2% 0.0% 0.0%   ROE %   60.5% 197.0% 156.1% 32.5% 196.1% 3.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.1% 7.6% 28.8% 14.5% 24.6% 2.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   130.6% 136.0% -65.8% 71.4% -17.8% 254.8% 0.0% 0.0%   Gearing %   69,114.1% 505.2% 25.9% 264.7% 40.0% 1,359.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.9% 7.2% 8.9% 7.3% 6.4% 9.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.8 1.3 0.7 0.9 0.7 0.0 0.0   Current Ratio   0.5 0.8 1.3 0.7 0.9 0.7 0.0 0.0   Cash and cash equivalent   15.4 26.5 1,403.6 232.2 495.1 168.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -851.3 -474.0 542.4 -559.4 -161.6 -607.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   289 197 348 169 327 52 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   289 197 348 169 323 52 0 0   EBIT / employee   160 94 263 66 224 15 0 0   Net earnings / employee   155 54 190 43 164 2 0 0